6 August 2020

Oxford PharmaGenesis colleagues volunteer their time to collate COVID-19 research for Evidence Aid

Throughout the COVID-19 pandemic, our colleagues have volunteered their time in many different and inspiring ways. Read more about the experiences of two of our colleagues.

Continue reading

3 July 2020

Oxford PharmaGenesis at the first virtual Communiqué Awards

This year saw the first virtual edition of the Communiqué Awards, with Oxford PharmaGenesis strongly represented among a multitude of faces online, celebrating excellence in international healthcare communications. While the COVID-19 pandemic precluded the razzmatazz of the usual black-tie dinner and awards ceremony in London, the virtual event nevertheless continued the Communiqué mission to recognize work that has delivered real improvements in healthcare and patient experience, built trust among wider stakeholders and augmented the reputation of our industry over the past year.

Continue reading

19 June 2020

ISMPP and Open Science – a perspective from Oxford PharmaGenesis

Our perspective

Champion sponsor of the Annual Meeting

Written by Chris Winchester, CEO, Oxford PharmaGenesis

This year’s virtual Annual Meeting of ISMPP marked the end of my 3 years on the Board of Trustees, and a chance to reflect on our achievements in that time. As well as managing the transition from one extremely talented President and CEO (Al Weigel) to another (Rob Matheis), we agreed a new mission and vision broadening our remit beyond publications to medical communications, and I was pleased to see that reflected strongly in the meeting program.

As a co-founder of Open Pharma, I was keen to use my time on the Board to advance Open Science, and so was proud that ISMPP made Open Access the subject of its first White Paper last year.

Of course, Open Access and preprints have played an important role in accelerating the scientific response to COVID-19, and I commend the program committee for making Open Science in general, and Open Access in particular, key themes of this year’s conference in the time of coronavirus.

Chris Winchester

1 2 3 4 5 31